Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
about
Physical energy for drug delivery; poration, concentration and activation.Physical approaches for nucleic acid delivery to liver.Engineering biodegradable and multifunctional peptide-based polymers for gene delivery.Carbohydrate polymers for nonviral nucleic acid delivery.Gene transfer to induce angiogenesis in myocardial and limb ischaemia.Therapeutic Use of 3β-[N-(N',N'-Dimethylaminoethane) Carbamoyl] Cholesterol-Modified PLGA Nanospheres as Gene Delivery Vehicles for Spinal Cord Injury.Long-circulating polymeric nanovectors for tumor-selective gene delivery.Targeted polymers for gene delivery.Targeting vascular endothelial growth factor in angina therapy.Polymers for DNA delivery.Pharmacokinetic considerations regarding non-viral cancer gene therapy.Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugateBioresponsive polymers for the delivery of therapeutic nucleic acids.Peptide-based cationic liposome-mediated gene delivery.Liver cell-targeted delivery of therapeutic molecules.Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting.Synthesis and in vitro testing of new potent polyacridine-melittin gene delivery peptidesModulation of the molecular conformation of a hepatocyte-targeting gene drug in order to improve its expression efficiency in vitro.A nonviral carrier for targeted gene delivery to tumor cells.Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential.Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.Gene delivery using a receptor-mediated gene transfer system targeted to hepatocellular carcinoma cells.Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver.Synthetic PEGylated glycoproteins and their utility in gene delivery.Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins.Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery.Improvement of hepatocyte-specific gene expression by a targeted colchicine prodrug.Multifunctional nanoparticles for gene delivery and spinal cord injury.Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation.Biodegradable nanoparticles for gene therapy technology
P2860
Q30412855-3F4FF854-60D3-4623-816F-6EEA29A2B0D2Q30484817-4DA84B60-F235-4BDA-A2DB-2F0FACDCF19AQ33589634-0862C766-86C8-4663-A99D-30EA3E109710Q33897565-082F9EB3-6A1F-4492-8876-7DDFE3CAB02EQ34452694-309B4E90-7F28-4095-A56A-EDBB7FC89CDAQ35908465-36EED0FB-42BA-42E1-8534-3CCA652496E0Q36314788-9C5F2207-0EBA-4FBE-861F-29AD1CC0ED33Q36316688-11D697F6-DC73-4C1A-9E6A-EE8413E0EA75Q36379360-1387124C-82C4-4D2F-85B6-300C17C7EFEBQ37002661-0A46077C-A76C-4008-9F3B-34F88A0E170BQ37092309-FEB95A5D-73BA-40F2-8C19-2E7B6CCE8BBBQ37217780-530979AC-5EC5-426D-81A1-B2C4D5AC9CF1Q37763677-5037FD7B-C991-4F31-8556-B46C42B31A6CQ37959027-5BCC46C9-C7C7-4FC8-8323-6E92E350EE2AQ38229624-02005897-43CD-4E20-8EAC-9A6736E4F6A0Q38972263-1A4A1821-2F14-450C-A087-E3D90D9AEB77Q39766098-8F41C006-0194-4B4E-8E98-A5B687B55708Q40466649-C4AD4829-4420-4E33-AF48-0F9AC4ADD637Q40603994-48B541D0-3D02-419C-8E1B-E2D4FA6AEC6BQ40678030-1EE8E596-D3AD-409C-B6E1-74784BC3D0B8Q40741120-51450936-D616-4F96-93C9-EAD703703A51Q40795424-C7214CF2-E062-4D0A-80B0-1C8833B5624DQ41566501-BB45EE29-0EC2-4EFD-B42E-C9C1DBFBA74EQ42174372-46879330-1105-469C-AA5D-C0F593CA13C2Q43746584-D7599C24-32F3-4199-BE07-BE6A74268C22Q43841715-79D9AF7C-F0C3-4690-A350-2F3359E47E0EQ44141063-6FFCC99B-7C9C-41DB-B6BE-6C43A1D17BA4Q44507364-E2690571-5D54-4A8C-97CE-1E38E3E3D17CQ45875230-EF4D6BCD-42A5-4278-9189-817CC69824A1Q45880236-9382889C-C5EF-4496-A3B8-35023B749253Q57920878-AFBE5260-3E39-40FC-BEE4-438419848E16
P2860
Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Hepatocyte-targeted in vivo ge ...... nctional gene delivery system.
@en
Hepatocyte-targeted in vivo ge ...... nctional gene delivery system.
@nl
type
label
Hepatocyte-targeted in vivo ge ...... nctional gene delivery system.
@en
Hepatocyte-targeted in vivo ge ...... nctional gene delivery system.
@nl
prefLabel
Hepatocyte-targeted in vivo ge ...... nctional gene delivery system.
@en
Hepatocyte-targeted in vivo ge ...... nctional gene delivery system.
@nl
P2093
P2860
P356
P1433
P1476
Hepatocyte-targeted in vivo ge ...... nctional gene delivery system.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301140
P577
2000-04-01T00:00:00Z
P5875
P6179
1036397363